Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
300039 Shanghai Kaibao Pharmaceutical
- 7.05
- +0.18+2.62%
Market Closed Dec 12 15:00 CST
7.37BMarket Cap21.17P/E (TTM)
7.09High6.80Low546.65KlotVolume6.87Open6.87Pre Close382.92MTurnover5.96%Turnover Ratio22.52P/E (Static)1.05BShares7.6052wk High1.91P/B6.46BFloat Cap4.9052wk Low8.24Limit Up916.93MShs Float18.28Historical High5.50Limit Down4.22%Amplitude2.60Historical Low0.10Dividend TTM7.00Avg Price234.15KlotAsk1.42%Div YieldTTM100Lot Size307.37KlotBid
Shanghai Kaibao Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -2.87%1.12B | -2.03%829.15M | 3.51%475.5M | 42.47%1.59B | 44.29%1.15B | 56.68%846.35M | 33.61%459.39M | 1.66%1.12B | 0.64%800.01M | 0.40%540.17M |
| Operating revenue | -2.87%1.12B | -2.03%829.15M | 3.51%475.5M | 42.47%1.59B | 44.29%1.15B | 56.68%846.35M | 33.61%459.39M | 1.66%1.12B | 0.64%800.01M | 0.40%540.17M |
| Other operating revenue | ---- | -84.56%145.23K | ---- | 34.59%3.03M | ---- | -32.59%940.74K | ---- | 73.95%2.25M | ---- | 328.75%1.4M |
| Interest income | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Commission income | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Premiums earned | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Total operating cost | -5.47%876.74M | -3.74%662.73M | 3.00%375.46M | 39.78%1.24B | 40.52%927.49M | 55.20%688.47M | 34.93%364.52M | -5.39%887.78M | -0.59%660.04M | 0.62%443.59M |
| Operating cost | -12.91%209.65M | -15.53%152.82M | -1.15%88.49M | 26.22%312.48M | 39.85%240.74M | 47.75%180.92M | 25.46%89.52M | 5.39%247.57M | 6.48%172.14M | 15.92%122.45M |
| Operating tax surcharges | -9.66%15.71M | -5.93%12.37M | 0.16%7.15M | 41.44%23.92M | 51.79%17.39M | 60.92%13.16M | 36.46%7.14M | 47.13%16.92M | 44.09%11.46M | 58.72%8.17M |
| Operating expense | -9.23%512.98M | -3.66%399.2M | -0.31%235.72M | 40.19%777.07M | 31.64%565.18M | 49.51%414.37M | 32.02%236.46M | -6.76%554.29M | -0.87%429.35M | -3.41%277.15M |
| Administration expense | 16.55%65.74M | 6.59%41.37M | 29.33%21.02M | 38.40%81.06M | 43.82%56.41M | 47.57%38.81M | 28.57%16.25M | 0.63%58.57M | -20.49%39.22M | -19.09%26.3M |
| Financial expense | -2.29%-29.61M | -4.10%-18.95M | -4.19%-9.31M | -16.33%-49.48M | -2.60%-28.95M | -18.16%-18.2M | -8.90%-8.93M | -6.22%-42.54M | -40.45%-28.22M | -10.40%-15.4M |
| -Interest expense (Financial expense) | --14.7K | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Interest Income (Financial expense) | -2.38%-29.72M | -4.14%-19.01M | -4.29%-9.34M | -16.26%-49.6M | -2.59%-29.03M | -18.09%-18.25M | -8.76%-8.95M | -5.77%-42.66M | -39.59%-28.29M | -9.56%-15.46M |
| Research and development | 33.29%102.27M | 27.78%75.93M | 34.50%32.38M | 81.01%95.87M | 112.59%76.73M | 138.38%59.42M | 140.34%24.08M | -33.23%52.97M | 12.84%36.09M | 1.43%24.93M |
| Credit Impairment Loss | 33.33%5.95M | 403.80%4.23M | 98.24%-115.82K | 178.37%5.33M | 7,105.53%4.46M | -205.95%-1.39M | -5.84%-6.56M | -104.04%-6.8M | 125.47%61.91K | 190.36%1.31M |
| Asset Impairment Loss | -98.78%1.7K | -99.61%1.7K | -99.52%1.7K | -143.16%-12.24M | -63.98%139.74K | -1.29%432.3K | 32.86%353.63K | -29.60%-5.03M | 181,053.68%387.99K | 204,380.69%437.96K |
| Other net revenue | 0.94%12.13M | -53.77%2.78M | 0.18%1.1M | 1,201.90%29.84M | 176.24%12.01M | 59.57%6.01M | 122.25%1.1M | -128.19%-2.71M | -65.14%4.35M | 15.88%3.76M |
| Fair value change income | -1,093.76%-3.62M | -563.04%-7.11M | -150.14%-1.77M | 49.41%-678.31K | 105.97%363.83K | 159.29%1.53M | 514.96%3.52M | -184.36%-1.34M | -228.03%-6.1M | -197.59%-2.59M |
| Invest income | 41.05%4.69M | -17.15%2.45M | -39.21%1.32M | 314.66%11.27M | -1.00%3.33M | 163.22%2.95M | 586.52%2.17M | -218.52%-5.25M | 336.22%3.36M | 176.20%1.12M |
| Net open hedge income | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Including: Investment income associates | ---- | ---- | --0 | 49.18%-4.55M | ---- | ---- | --0 | ---8.96M | ---- | ---- |
| Exchange income | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Asset deal income | ---11.92K | ---11.92K | ---11.92K | -18.61%-206.64K | ---- | ---- | --0 | 20.50%-174.22K | 74.52%-11.44K | 61.52%-11.44K |
| Other revenue | 37.34%5.11M | 29.60%3.21M | 3.77%1.67M | 65.94%26.37M | -44.01%3.72M | -28.95%2.48M | 4.98%1.61M | 44.18%15.89M | -8.02%6.65M | -1.84%3.49M |
| Operating profit | 7.44%256.62M | 3.24%169.19M | 5.39%101.14M | 67.69%382.96M | 65.51%238.86M | 63.32%163.89M | 39.63%95.97M | 32.90%228.37M | 0.60%144.32M | -0.09%100.35M |
| Add:Non operating Income | -96.02%2.03K | 123.94%1.86K | --1.33K | 2,033.17%1.08M | 96.83%50.93K | -96.72%830 | --0 | 117.69%50.76K | --25.87K | --25.29K |
| Less:Non operating expense | -36.24%153.63K | -64.06%50K | --0 | -77.18%508.01K | -59.73%240.95K | -49.23%139.11K | -63.50%100K | 1.21%2.23M | -54.16%598.31K | 19.13%274K |
| Total profit | 7.46%256.47M | 3.30%169.15M | 5.50%101.14M | 69.56%383.53M | 66.03%238.67M | 63.59%163.75M | 39.99%95.87M | 33.33%226.19M | 1.12%143.75M | -0.11%100.1M |
| Less:Income tax cost | -7.01%39.83M | -4.98%27.24M | -18.46%12.84M | 56.86%56.63M | 66.66%42.84M | 60.85%28.67M | 38.90%15.75M | 22.23%36.11M | -3.56%25.7M | -3.20%17.82M |
| Net profit | 10.62%216.64M | 5.05%141.9M | 10.21%88.3M | 71.98%326.9M | 65.90%195.83M | 64.18%135.08M | 40.21%80.12M | 35.67%190.08M | 2.20%118.04M | 0.59%82.27M |
| Net profit from continuing operation | 10.62%216.64M | 5.05%141.9M | 10.21%88.3M | 71.98%326.9M | 65.90%195.83M | 64.18%135.08M | 40.21%80.12M | 35.67%190.08M | 2.20%118.04M | 0.59%82.27M |
| Net income from discontinuing operating | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Less:Minority Profit | -47.19%-430.68K | -13.08%-235.68K | -163.11%-159.79K | -35.09%-972.31K | 48.52%-292.59K | 58.65%-208.42K | 87.70%-60.73K | -30,953.27%-719.74K | ---568.37K | ---504.01K |
| Net profit of parent company owners | 10.68%217.07M | 5.07%142.14M | 10.33%88.46M | 71.84%327.87M | 65.35%196.12M | 63.44%135.29M | 39.11%80.18M | 36.18%190.8M | 2.70%118.61M | 1.21%82.78M |
| Earning per share | ||||||||||
| Basic earning per share | 10.67%0.2075 | 5.10%0.1359 | 10.30%0.0846 | 71.88%0.3135 | 65.34%0.1875 | 63.46%0.1293 | 39.20%0.0767 | 36.12%0.1824 | 2.72%0.1134 | 1.15%0.0791 |
| Diluted earning per share | 10.67%0.2075 | 5.10%0.1359 | 10.30%0.0846 | 71.88%0.3135 | 65.34%0.1875 | 63.46%0.1293 | 39.20%0.0767 | 36.12%0.1824 | 2.72%0.1134 | 1.15%0.0791 |
| Other composite income | -294.20%-290M | -1,094.68%-559.4M | -224.75%-341.46M | -99.14%4.35M | -112.57%-73.57M | -95.80%56.24M | 152.63%273.71M | 42.08%508.45M | 56.86%585.31M | 1.34B |
| Other composite income of parent company owners | -294.20%-290M | -1,094.68%-559.4M | -224.75%-341.46M | -99.14%4.35M | -112.57%-73.57M | -95.80%56.24M | 152.63%273.71M | 42.08%508.45M | 56.86%585.31M | --1.34B |
| Other composite income of minority owners | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Total composite income | -160.00%-73.36M | -318.22%-417.5M | -171.55%-253.16M | -52.58%331.25M | -82.62%122.26M | -86.53%191.32M | 113.81%353.83M | 40.28%698.53M | 43.94%703.35M | 1,637.02%1.42B |
| Total composite income of parent company owners | -159.51%-72.93M | -317.86%-417.26M | -171.49%-253M | -52.49%332.22M | -82.59%122.56M | -86.52%191.53M | 113.21%353.89M | 40.42%699.25M | 44.06%703.92M | 1,637.64%1.42B |
| Total composite income of minority owners | -47.19%-430.68K | -13.08%-235.68K | -163.11%-159.79K | -35.09%-972.31K | 48.52%-292.59K | 58.65%-208.42K | 87.70%-60.73K | -30,953.27%-719.74K | ---568.37K | ---504.01K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
